Miramar, FL, United States of America

Karen Kage

This inventor holds 2 USPTO granted patents and 2 published patent applications, plus 2 CIPO patents and 1 EPO patent. Top assignee: Altor Bioscience Corporation. Active years: 2022.

USPTO Granted Patents = 2 

% Patents Active = 100.0


 

Average Co-Inventor Count = 9.0

ph-index = 2

Forward Citations = 17(Granted Patents)


Company Filing History:


Years Active: 2022

Loading Chart...
Loading Chart...
Loading Chart...
2 patents (USPTO):Explore Patents

Title: The Innovative Contributions of Karen Kage

Introduction

Karen Kage is a notable inventor based in Miramar, FL (US). She has made significant contributions to the field of biotechnology, particularly in the development of multi-specific protein complexes. With a total of 2 patents, her work has the potential to impact therapeutic approaches for various diseases.

Latest Patents

Karen's latest patents include the invention of multimeric IL-15-based molecules. This invention features multi-specific protein complexes that comprise one domain consisting of IL-15 or a functional variant, along with a binding domain specific to a disease antigen, immune checkpoint, or signaling molecule. This innovative approach could lead to advancements in targeted therapies.

Career Highlights

Throughout her career, Karen has worked with prominent companies in the biotechnology sector. She has been associated with Altor Bioscience Corporation and Nantcell, Inc., where she has contributed her expertise in protein engineering and therapeutic development.

Collaborations

Karen has collaborated with esteemed colleagues, including Hing C Wong and Warren Marcus. These partnerships have fostered a collaborative environment that enhances innovation and research in her field.

Conclusion

Karen Kage's contributions to biotechnology through her patents and collaborations highlight her role as a leading inventor. Her work continues to pave the way for advancements in medical therapies.

This text is generated by artificial intelligence and may not be accurate.
Please report any incorrect information to [email protected]
Loading…